Search

everythinglearnresearchcommunity

for

Search:↓

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

Spironolactone effectively reduces symptoms of hyperandrogenism like hirsutism and acne.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Spironolactone nano-formulations show promise for treating skin disorders, but more research is needed for safety and effectiveness.

Total testosterone levels can help diagnose androgen-producing tumors and hyperandrogenism in women.

Biochemical markers help diagnose ovarian tumors in postmenopausal women.

Spironolactone may help reduce excessive hair growth in women with high male hormone levels.

Excessive male hormones in women cause symptoms like unwanted hair growth, and treatment requires careful medical evaluation.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Finger length ratios might help predict common hair loss.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Lab tests for female hair loss have unclear usefulness; consider based on symptoms.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

PSA can help diagnose high androgen levels in women.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Postmenopausal women with past hirsutism or irregular periods have more heart and lung diseases.